StockMacro
Company, fund or insider

Help

Menu

CapsoVision

$6.11 -7.7% in 6 monthsMarket cap $327.6M

CV on XNAS, Health Care, CapsoVision, Inc., job postings

Measures activity, not value. Not investment advice.

Insiders bought $15M and sold nothing in 90 days while net loss reached $29.2M.

  • GoodRevenue up 6.4% to $13.9M, 12 months to September 2026

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

CapsoVision Inc is a commercial-stage medical technology enterprise that innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system. The company's core technology platform is an orally ingestible capsule including multiple cameras facilitating 360-degree imaging, light-emitting diodes for measurement, onboard memory storage, and battery life permitting recording and onboard storage of video images. CapsoVision's products consist of the on-market CapsoCam Plus, directed at the small intestines, and the in-development CapsoColon 3D, directed at the large intestines. Geographically, the company generates the majority of its revenue from the United States.

Industry
Electromedical & electrotherapeutic apparatus (Health Care)
Employees
99
Website
capsovision.com
Listed
Nasdaq, US
Last results
12 Nov 2026
Next results
expected around 19 Mar 2027 (an estimate: a year ago it reported on 20 Mar 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $3.6M, net loss $7.3M.
Quarter to 31 Mar 2024: revenue –, net income -$4.2MQuarter to 30 Jun 2024: revenue $2.8M, net income -$5.3MQuarter to 30 Jun 2024: revenue $2.8M, net income -$5.3MQuarter to 30 Sep 2024: revenue $3.0M, net income -$5.8MQuarter to 30 Sep 2024: revenue $3.0M, net income -$5.8MQuarter to 31 Dec 2024: revenue $3.5M, net income -$4.6MQuarter to 31 Dec 2024: revenue $3.5M, net income -$4.6MQuarter to 31 Mar 2025: revenue $2.8M, net income -$5.4MQuarter to 31 Mar 2025: revenue $2.8M, net income -$5.4MQuarter to 30 Jun 2025: revenue $3.3M, net income -$4.6MQuarter to 30 Jun 2025: revenue $3.3M, net income -$4.6MQuarter to 30 Sep 2025: revenue $3.5M, net income -$7.9MQuarter to 30 Sep 2025: revenue $3.5M, net income -$7.9MQuarter to 31 Dec 2025: revenue $3.9M, net income -$7.4MQuarter to 31 Dec 2025: revenue $3.9M, net income -$7.4MQuarter to 31 Mar 2026: revenue $2.8M, net income -$7.0MQuarter to 31 Mar 2026: revenue $2.8M, net income -$7.0MQuarter to 30 Jun 2026: revenue $3.6M, net income -$7.5MQuarter to 30 Jun 2026: revenue $3.6M, net income -$7.5MQuarter to 30 Sep 2026: revenue $3.6M, net income -$7.3MQuarter to 30 Sep 2026: revenue $3.6M, net income -$7.3M
31 Mar 2024RevenueNet incomeNet losstallest bar $7.9M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$3.6M-$7.3M
30 Jun 2026$3.6M-$7.5M
31 Mar 2026$2.8M-$7.0M
31 Dec 2025$3.9M-$7.4M
30 Sep 2025$3.5M-$7.9M
30 Jun 2025$3.3M-$4.6M
31 Mar 2025$2.8M-$5.4M
31 Dec 2024$3.5M-$4.6M
30 Sep 2024$3.0M-$5.8M
30 Jun 2024$2.8M-$5.3M
31 Mar 2024–-$4.2M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $13.9M $13.1M
Revenue growthRevenue of the last 12 months compared with the 12 months before. +6.4% +19%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$29.2M -$22.6M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). -$0.43 -$6.88
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 49.7% 53.1% 61.8%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. -212% -173% -24.9%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. -210% -172% -33.5%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. -125% -77.7%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. – -$20.7M
CashCash, cash equivalents and short-term investments on the latest balance sheet. – –
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. – –
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). – –
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. – 0.32
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $0.49
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 24.4
P/SPrice to sales: market cap divided by revenue of the last 12 months. 23.5 3.0
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. – 2.6
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 12.4 3.6

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
CapsoVisionCV (this company) $327.6Mloss23.5+6.4%-210%
ElectromedELMD $187.8M15.82.5+14%15.8%
Vivani MedicalVANI $102.8Mloss–––
CeriBellCBLL $1.1Bloss9.8+31%-68.0%
StereotaxisSTXS $95.0Mloss3.0+4.8%-70.9%
ConmedCNMD $1.4B––––

Insider buy/sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

+$15.0M

bought $15.0M, sold $0

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

0%

49 13F filers vs 49

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

12%

6.2M shares held by 13F filers (30 Sep 2026) of 53.6M outstanding (11 Nov 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

3.6%

2.0M shares sold short (30 Oct 2026) of 53.6M outstanding (11 Nov 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

14.3

2.0M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-11%

2.2M shares sold short in the report before, 2.0M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

89%

89% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 69%

News Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

0

0 articles in the last 7 days; its usual week has 0 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

–

0 articles in the last 7 days; its usual week has 0: fewer than one, so there is nothing to compare with.

Price $6.11 on 20 Nov 2026, +15% over 12 months (12-month range $4.64 to $14.42)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders bought a net $16.0M in the last 12 months (the 12 months before: $0).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 0 published in the last 12 months, -100% on the 12 months before.
Revenue per quarter. Revenue $3.6M in the latest quarter, +0.8% on a year earlier.
Capital spending per quarter. Capital spending $22K in the latest quarter, +83% on a year earlier.
Institutional holders (13F filers). 49 13F filers reported holding it in the latest 13F quarter, +88% on a year earlier.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: federal obligations, lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
18 Aug 2026Sharp changeShort interest spike: short interest spike, 1.9M vs usual 289K (2026-07-31); 149.3x the same period a year earlier
2 Jul 20268-K and other filingsDirector or officer change
2 Jul 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
17 Apr 20268-K and other filingsRegistered new securities for sale (S-1)
3 Nov 20258-K and other filingsDirector or officer change
26 Sep 20258-K and other filingsDirector or officer change
3 Sep 20258-K and other filingsDirector or officer change
3 Sep 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
26 Jun 20258-K and other filingsRegistered new securities for sale (S-1)
13 Jun 20258-K and other filingsRegistered new securities for sale (S-1)
30 May 20258-K and other filingsRegistered new securities for sale (S-1)
9 May 20258-K and other filingsRegistered new securities for sale (S-1)
Insider net buying (open market)
Month from 1 Jul 2026: $1.0M published
Month from 1 Sep 2026: $15.0M published
H-1B/E-3 applications certified
Quarter from 1 Oct 2022: 2 published
Quarter from 1 Jan 2024: 3 published
Quarter from 1 Oct 2024: 2 published
Quarter from 1 Jul 2025: 2 published
Revenue per quarter
Quarter ended 30 Jun 2024: $2.8M; public on 15 Aug 2025
Quarter ended 30 Sep 2024: $3.0M; public on 14 Nov 2025
Quarter ended 31 Dec 2024: $3.5M; public on 27 Mar 2026
Quarter ended 31 Mar 2025: $2.8M; public on 15 May 2026
Quarter ended 30 Jun 2025: $3.3M, +17% on a year earlier; public on 15 Aug 2025
Quarter ended 30 Sep 2025: $3.5M, +19% on a year earlier; public on 14 Nov 2025
Quarter ended 31 Dec 2025: $3.9M, +13% on a year earlier; public on 27 Mar 2026
Quarter ended 31 Mar 2026: $2.8M, +0.3% on a year earlier; public on 15 May 2026
Quarter ended 30 Jun 2026: $3.6M, +9.9% on a year earlier; public on 14 Aug 2026
Quarter ended 30 Sep 2026: $3.6M, +0.8% on a year earlier; public on 13 Nov 2026
Capital spending per quarter
Quarter ended 30 Sep 2024: $4K; public on 14 Nov 2025
Quarter ended 31 Dec 2024: $0; public on 27 Mar 2026
Quarter ended 31 Mar 2025: $40K; public on 15 May 2026
Quarter ended 30 Jun 2025: $30K; public on 15 Aug 2025
Quarter ended 30 Sep 2025: $12K, +200% on a year earlier; public on 14 Nov 2025
Quarter ended 31 Dec 2025: $8K; public on 27 Mar 2026
Quarter ended 31 Mar 2026: $48K, +20% on a year earlier; public on 15 May 2026
Quarter ended 30 Sep 2026: $22K, +83% on a year earlier; public on 13 Nov 2026
Institutional holders (13F filers)
30 Sep 2025 report: 26; public on 14 Nov 2025
31 Dec 2025 report: 31; public on 17 Feb 2026
31 Mar 2026 report: 49; public on 15 May 2026
30 Jun 2026 report: 49; public on 14 Aug 2026
30 Sep 2026 report: 49; public on 16 Nov 2026

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is insider open-market buying (USD, Form 4) at $10.0M (23 Sep 2026), 22× its normal reading; higher than 100% of its own history.
  • Short interest spike: had 1.9M shares sold short in the 31 Jul 2026 report, 149× the same report last year Public on 12 Aug 2026.
  • Insider net buying (open market): Insiders bought a net $16.0M in the last 12 months (the 12 months before: $0).
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 0 published in the last 12 months, -100% on the 12 months before.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 8 insider trades

Last 90 days: no sales; 2 purchases, $15.0M. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
23 Sep 2026Eliyahou Et Al Harari10% ownerBuy1,757,469$5.69$10.0MForm 4
18 Sep 2026Ching Hang Shen10% ownerBuy878,734$5.69$5.0MForm 4
21 Jul 2026Eliyahou Et Al Harari10% ownerBuy61,068$6.73$411KForm 4
10 Jul 2026Eliyahou Et Al Harari10% ownerBuy81,300$6.09$495KForm 4
7 Jul 2026Eliyahou Et Al Harari10% ownerBuy13,850$7.35$102KForm 4

49 institutions reported shares at the end of Q3 2026, 12% of the shares outstanding; 5 opened a position, 5 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.2.3M4.34%$15.0M+432K+23%
Vanguard Capital Management LLC1.3M2.50%$8.7M+283K+27%
Geode Capital Management, LLC853K1.59%$5.5M+274K+47%
State Street Corp487K0.91%$3.1M+77K+19%
Vanguard Fiduciary Trust Co261K0.49%$1.7M+157K+152%
Vanguard Portfolio Management LLC245K0.46%$1.6M+4,121+1.7%
UBS Group AG133K0.25%$857K+125K18 times as many
Charles Schwab Investment Management Inc85K0.16%$549K+5,680+7.2%
Bank of New York Mellon Corp75K0.14%$487K+366+0.5%
Goldman Sachs Group Inc65K0.12%$420K+46K+249%

Company events

All 20 company events

In 12 months: 4 major agreements, 1 share registration, 1 director or officer change. Results releases and routine reports are left out.

FiledWhat happenedSource
18 Sep 2026Signed a major agreement8-K
13 Aug 2026Signed a major agreement8-K
2 Jul 2026Director or officer change8-K
17 Apr 2026Registered new securities for sale (S-1)S-1
20 Mar 2026Signed a major agreementSame filing: sold shares privately8-K
13 Mar 2026Signed a major agreement8-K
3 Nov 2025Director or officer change8-K
26 Sep 2025Director or officer change8-K
Timeline
Kind of data

Timeline

Changes and notable records, by the date each became public

  1. 24 Sep 2026Insiders record

    Shen Ching Hang (ten percent owner) bought 878,734 shares of cv ($5.0M) [amended] (dated 23 Sep 2026)

  2. 24 Sep 2026Insiders record

    HARARI ELIYAHOU ET AL (ten percent owner) bought 1,757,469 shares of CV ($10.0M) (dated 23 Sep 2026)

  3. 19 Sep 2026Insiders record

    Shen Ching Hang (ten percent owner) bought 878,734 shares of cv ($5.0M) (dated 18 Sep 2026)

  4. 12 Aug 2026Short interest and volume change

    had 1.9M shares sold short in the 31 Jul 2026 report, 149× the same report last year.

    Same report last year: 13K; its normal report is 289K.

    See the evidence
    This period
    1.9M (the 31 Jul 2026 report)
    Normal report (median of 24 earlier)
    289K
    Typical spread (median absolute deviation)
    270K
    How far from its usual level
    +4.1
    Same report last year
    13K
    History used
    381 days
    2025-07-31: 13K2025-08-15: 4,1612025-08-29: 1,9852025-09-15: 11K2025-09-30: 42K2025-10-15: 36K2025-10-31: 38K2025-11-14: 38K2025-11-28: 79K2025-12-15: 215K2025-12-31: 220K2026-01-15: 94K2026-01-30: 358K2026-02-13: 429K2026-02-27: 409K2026-03-13: 553K2026-03-31: 1.2M2026-04-15: 1.4M2026-04-30: 1.4M2026-05-15: 1.4M2026-05-29: 1.4M2026-06-15: 1.5M2026-06-30: 1.7M2026-07-15: 2.1M2026-07-31: 1.9M
    the 31 Jul 2026 report24 earlier reportsnormal: 289K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  5. 22 Jul 2026Insiders record

    HARARI ELIYAHOU ET AL (ten percent owner) bought 61,068 shares of CV ($410,988) (dated 21 Jul 2026)

  6. 11 Jul 2026Insiders record

    HARARI ELIYAHOU ET AL (ten percent owner) bought 81,300 shares of CV ($495,117) (dated 10 Jul 2026)

  7. 8 Jul 2026Insiders record

    HARARI ELIYAHOU ET AL (ten percent owner) bought 13,850 shares of CV ($101,798) (dated 7 Jul 2026)

  8. 2 Jul 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  9. 2 Jul 2026Filings record

    Director or officer change

  10. 17 Apr 2026Filings record

    Registered new securities for sale (S-1)

  11. 7 Feb 2026Insiders record

    Tsai Chen Lung (director) bought 20 shares of CV ($83) [amended] (dated 6 Feb 2026)

  12. 3 Nov 2025Filings record

    Director or officer change

  13. 26 Sep 2025Filings record

    Director or officer change

  14. 3 Sep 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  15. 3 Sep 2025Filings record

    Director or officer change

  16. 26 Jun 2025Filings record

    Registered new securities for sale (S-1)

  17. 13 Jun 2025Filings record

    Registered new securities for sale (S-1)

  18. 30 May 2025Filings record

    Registered new securities for sale (S-1)

  19. 9 May 2025Filings record

    Registered new securities for sale (S-1)

  20. 17 Jun 2020Filings record

    Private placement of securities (Form D)

  21. 26 Nov 2019Filings record

    Private placement of securities (Form D)

  22. 31 Oct 2018Filings record

    Private placement of securities (Form D) (dated 30 Oct 2018)

  23. 30 Oct 2018Filings record

    Private placement of securities (Form D)

  24. 23 Apr 2016Filings record

    Private placement of securities (Form D) (dated 22 Apr 2016)

Not listed: 27 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001378325
Ticker
CV
Domain
capsovision.com
Employer name
CapsoVision, Inc. (1 unverified)
Hq location
CA|SARATOGA|95070 (1 unverified)
Name
Capso Vision Inc, CapsoVision, Inc.
  • DOL H-1B labor condition applications and PERM certifications61 data points29 Jun 2020 to 20 Apr 2026
  • SEC Form 13F institutional holdings45 data points30 Sep 2025 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)40 records22 Apr 2016 to 12 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)154 data points31 Dec 2023 to 11 Nov 2026
  • SEC Form 4 insider transactions8 records, 20 data points6 Feb 2026 to 23 Sep 2026
  • FINRA short interest (twice monthly)95 data points15 Jul 2025 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)702 data points2 Jul 2025 to 20 Nov 2026